Nexavar (sorafenib) — Medica
Differentiated thyroid carcinoma (radioactive iodine refractory)
Initial criteria
- age ≥ 18 years
- differentiated thyroid carcinoma (papillary, follicular, or Hürthle cell)
- disease refractory to radioactive iodine therapy
Approval duration
1 year